I te mea e akiaki ana ngā mana hauora o te ao kia wawe te tautuhi i te mate HIV, kei te tere ake ngā kaihanga tautuhi i te whanaketanga o ngā tūāpapa whakamātautau e hangai ana ki te antigen p24, me ngā whakamātautau o te whakatupuranga tuawhā kua eke ki te pakeketanga arumoni puta noa i ngā mākete maha.

Ko te pūmua p24, he pūmua kapsid huaketo, ka kitea i roto i ngā rā 10 ki te 14 i muri i te pangia e te HIV — he rā i mua i te putanga mai o ngā paturopi. Nā tēnei painga koiora kua waiho te p24 hei tūāpapa mō ngā rautaki whakamātautau HIV o te whakatupuranga tuawhā, e kitea ai te pūmua p24 me ngā paturopi HIV i te wā kotahi hei whakawhāiti i te wā matapihi tātaritanga.

Te Manawanui Tauhokohoko

I te WHX Labs Bangkok 2026, i whakaatu te kaihanga tātaritanga Hainamana a Wondfo i tana whakamātautau tere HIV o te whakatupuranga tuawhā ki te Pirimia o Thailand, a Anutin Charnvirakul, e whakaatu ana i te kaha o te whakamātautau ki te kite i te mate tata ki te wiki kotahi i mua atu i ngā whakamātautau paturopi anake. I ripoata te kamupene i te 100% te aro me te 99.71% te motuhake mō te whakamātautau paturopi HIV-1/2 me te antigen p24.

I te Hononga o Amerika, kua tere tonu ngā whakaaetanga a ngā ture. Kua whakaaetia e te FDA ngā tūāpapa kimi p24 maha i te tau 2026, tae atu ki te whakamātautau LIAISON MUREX HIV Ab/Ag HT a DiaSorin me te whakamātautau HIV Combo Next a Abbott mō te tūāpapa Alinity i. Ko ēnei e rua he whakamātautau ārai mate chemiluminescent e kaha ana ki te kimi i te antigen HIV p24 i te wā kotahi me ngā paturopi ki te HIV-1 me te HIV-2.

I te marama o Hune 2026 i puta ai tētahi tohu nui mō te hauora tūmatanui, i te wā i whakamahia ai e Seychelles me Eritrea te Determine Antenatal Care Panel a Abbott — te whakamātautau tere tuatahi kua whakamanahia e te WHO e whakauru ana i te kitenga HIV o te whakatupuranga tuawhā me te tirotiro syphilis me te hepatitis B mai i tētahi tauira wero kotahi maihao.

Ngā Rohe Rangahau

Haunga ngā tātaritanga arumoni, kei te whai ngā kairangahau mātauranga i te kitenga p24 tino tairongo mā roto i ngā tūāpapa e hangai ana ki te microfluidic me te nanomaterial. Nō nā tata nei i pūrongohia e tētahi rōpū mai i Te Whare Wānanga o Tsinghua tētahi pūoko koiora fluorescence microfluidic e tutuki ana i te rohe kitenga 18.48 pg/mL mō te p24, mā te whakamahi i ngā rautaki whakanui tohu kore-enzyme. I tua atu, i whakaatu ngā kairangahau i tētahi pūnaha microfluidic chemiluminescence cascading me te aronga paturopi me te whakarei ake tohu e whakahaerehia ana e te nanoparticle koura, e aro ana ki ngā tono tiaki-tūturu i roto i ngā tautuhinga iti-rauemi.

Ngā Whakaaro Hauora

Ahakoa ngā whanaketanga, kei te mau tonu ngā wero. I roto i tētahi rangahau i te tau 2026 i arotake i te whakamātautau VIDAS DUO AG/AB a bioMérieux ki tōna mua, i kitea he nui ngā reiti o ngā tohu antigen p24 kāore i te tino mōhiotia i te wā o te whakarōpūtanga mate pāwera, e whakaatu ana i te uaua o te tautuhi i te wā tōmua. Hei tāpiri, i whakaatuhia e ngā rangahau tata nei ka kitea te antigen p24 i muri i te wehenga o ngā matatini ārai mate i roto i ngā tauira he nui ake i te 10⁴ ngā tārua/mL ngā kawenga huaketo, e kī ana ka huna pea ngā matatini ārai mate e rere ana i te toto i te kitenga antigen i ētahi wā.

E pupuri ana te WHO i ngā paearu mahi mō te rapunga tātaritanga HIV, me te hiahia kia 100% te aro o ngā whakamātautau ārai mate whākōkī e kite ana i te anti-HIV-1/2 me te HIV-1 p24 antigen, me te motuhaketanga ki te 98%, neke atu rānei.

I te mea e whakapai ake ana ngā kaihanga i ngā tūāpapa o te whakatupuranga tuawhā, ā, e whakaiti ana ngā kairangahau i ngā herenga kitenga, kua rite te tātaritanga e hangai ana ki te antigen p24 ki te noho hei pokapū mō ngā rautaki ā-ao mō te tautuhi i te mate HIV whakapeka me te whakakore i ngā mekameka tuku.

Ka taea e mātou a Baysen Medical te tukuKete whakamātautau tere HIV/P24me te whakamātautau kounga me te whakamātautau tauanga. Nau mai ki te whakapiri mai ki a mātou mēnā he tono āu.